As an expert in epidemiological research using multi-omics methods, I aim to revolutionize nutritional epidemiology, focusing on individualization and meaningfulness. Leveraging my background as an occupational physician, I intend to apply these advancements to workplace health, emphasizing evidence-based improvements for employee well-being. Dedicated to transforming advanced research into practical workplace solutions, my goal is to seamlessly integrate scientific discoveries with day-to-day occupational health practices, ensuring multi-omics research is effectively utilized at a fundamental level. My ambition is to create a significant impact in both the academic sphere and the industry through persistent research and collaboration.

After working as a clinical anesthesist and an attending physician in Shanghai, China for 7 years, I finally have the chance to come to Japan and begin my PhD. program, which is my dream for all the time. Then, I paid my full passion and execution to explore the attractive research world. As a researcher, it is important to pursue the expansion of knowledge and insights in my own research area, as well as contribute to academia through new discoveries and the development of technology. Applying one’s own research outcomes and insights to society and positively impacting real-world problems and social issues is every researcher’s expection. And in the future far away, I may aim to focus on how my research contributes to medical and societal changes.

Evolutionary divergent ERVs insertion shapes host transcriptome during preimplantation development.RNA-seq analysis showed that ZGA in hamster occurs at the two-cell stage, similar to that in mice. Furthermore, interspecies comparisons of human, hamster, and mouse early embryonic transcriptomes revealed that ZGA genes and their expression dynamics are highly species-specific. Furthermore, evolutionarily young hamster-specific ERV1 and ERVK factors are enriched near the hamster ZGA locus, and these ERVs provide species specificity, suggesting that this may drive ZGA and control the expression of endogenous genes.

私は現在、医学研究科にてwell-beingの観点からさまざまなデータ検証を行わせていただいております。同時に、医学部で医学を学ばせていただいており、将来的にはこれらの知を融合し、複合的な視座を持って社会に貢献していきたいと考えております。

I think the research and career prospects for microbiologists are diverse and the field continues to evolve with advancement in technology and our understanding of microorganisms. As I am working with microorganisms beneficial to the human health, I would like to continue to pursue careers in academia, working at the Keio University Honda Laboratory, to conduct research on various aspects of microbiology and contribute to scientific advancements. Another pathway I could take is to work at the Keio University Hospital, to analyze patient samples to identify and treat infections. I would like to contribute to epidemiological studies and public health efforts.

I have been dedicated to myopia research for the past two years because the complications of myopia bring a great burden to people’s quality of life and social economy. With the development of society and the popularization of electronic products, simple myopia seems to be inevitable. However, simple myopia does not suddenly transform into pathological myopia, and there should be a gradual deterioration process during this period, my research is searching for such a state and indicator to gain a deeper understanding and prevent complications of myopia, improve the lifelong quality of life of myopic individuals.
I have been an ophthalmologist for 10 years before, so I have a better understanding of clinical needs. I will promote my research results in the clinic in the future.

本研究が組織採取や疾患モデルの開発が問題となる様々な疾患の新たな研究・治療戦略開発の一助になればと思う。自身の将来像としては、今後も実際の臨床現場に赴き問題点に対峙することで、患者および医療現場のニーズに沿った新たな診断・治療法開発のアイデアを生みつつ、他分野の人材とも連携し、より大きな規模の研究を主導できる立場になり、様々な研究者のアイデアを社会に生かせるような仕組み作りに寄与したい。

現在、自治体と連携したウェルビーイングに関する調査研究や、産官学連携によるイノベーション推進プロジェクト、研究機関やNPO等と連携した女性の健康に関する調査研究等に携わっています。研究テーマとしては、特に、仕事と治療の両立支援に関心を持っています。今後も、社会人経験を活かしながら、自治体や企業等と連携し、研究の社会実装推進に取り組んでいきたいと考えています。

My research is dedicated to developing new drugs and therapies for retinal vascular diseases and expanding the understanding of them. The ever-evolving challenges of research fuel my curiosity and bring a deep sense of accomplishment. I aim to integrate emerging technologies like AI and gene therapy to revolutionize diagnostics and treatment protocols. I am also committed to contributing to a dynamic, collaborative scientific community focused on mitigating the impact of retinal diseases worldwide. Valuing the research opportunity provided by Keio University, I am resolved to persistently apply my efforts toward these endeavors.